Search clinical trials for: Rituximab-CHOP

Total 3495 results

Sun Yat-sen University
Chipscreen Biosciences, Ltd.

Not yet recruiting

Anti-PD-1 Antibody Plus Chidamide and Rituximab Regimen in Relapsed or Refractory DLBCL (PCR) (PCR)

Relapsed or Refractory DLBCL
Assistance Publique - Hôpitaux de Paris
Roche Pharma AG

Completed

Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)

ANCA-associated Vasculitides

France
University of Wisconsin, Madison
Genentech, Inc.

Terminated

Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance

Non-Hodgkin's Lymphoma

United States
Charite University, Berlin, Germany

Unknown

Zevalin® First Line in Follicular Lymphoma

Follicular Lymphoma
Chinese University of Hong Kong

Completed

Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Lymphoma Study Association
Amgen

Completed

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

Untreated CD20-positive Large B-cell Lymphoma

France
National University Hospital, Singapore
National University of Singapore

Unknown

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Non-Hodgkin's Lymphoma | B-Cell Chronic Lymphocytic Leukemia

Singapore
Joseph Tuscano
National Cancer Institute (NCI); ADC Therapeutics S.A.

Recruiting

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

United States
OHSU Knight Cancer Institute
AbbVie; Oregon Health and Science University

Recruiting

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

B Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute Leukemia

United States
University Hospital Southampton NHS Foundation...
AstraZeneca

Recruiting

Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) (REMoDL-A)

Diffuse Large B Cell Lymphoma

United Kingdom
Chinese University of Hong Kong
Shanghai Children's Medical Center

Completed

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Acute Lymphoblastic Leukemia, in Relapse

Hong Kong
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia (RITUX PLUS)

Immune Thrombocytopenia

France
Biogen

Terminated

Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin's
University Hospital, Brest
Ministry of Health, France

Completed

Tolerance and Efficacy of Rituximab in Sjogren's Disease (TEARS)

Sjogren's Disease

France
Celltrion

Terminated

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial (Triad-DLBCL)

Diffuse Large B-Cell Lymphoma

Korea, Republic of
Loma Linda University

Recruiting

Exploring the Effectiveness of Dance as an Intervention to Promote Social-Emotional Health in Children With Autism Spectrum Disorder (ASD) (ASD)

Autism Spectrum Disorder

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Zhejiang Provincial Center for Disease Control and Prevention

Completed

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

COVID-19

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Refractory Aggressive Non-Hodgkin Lymphoma

United States
CTI BioPharma

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (PIX-R)

Diffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 Lymphoma

United States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
Cancer Research UK
BioInvent International AB; Bloodwise

Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

B-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic Leukaemia

United Kingdom
RTI International
Kheth'Impilo

Completed

Implementation Research for Vulnerable Women in South Africa

HIV | Substance Abuse

United States, South Africa
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Coronavirus Disease 2019

China
Laval University
Dairy Farmers of Canada; Agriculture and Agri-Food Canada

Completed

Study of the Impact of Dairy Fat on Cardiovascular Health. (HDL)

Metabolic Syndrome

Canada
University of Nottingham
Action Medical Research

Completed

Helping Our Premature Infants ON to Better Motor Skills (HOP-ON) (HOP-ON)

Motor Development of Premature Infants

United Kingdom
Nordic Lymphoma Group
AstraZeneca

Active, not recruiting

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma (ALTAMIRA)

Mantle Cell Lymphoma | MCL

Finland, Sweden, Norway, Denmark, Korea, Republic of
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin | Child, Only
Asociacion Doctor Peset Para el Estudio de la Hematología
Cephalon; Pivotal S.L.

Unknown

Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk

No Hodgkin B Lymphoma

Spain
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation...

Completed

B Cell Induction in Pediatric Lung Transplantation

Lung Transplant

United States
GlaxoSmithKline

Completed

Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

Sjogren's Syndrome

Spain, France, Germany, Netherlands, United Kingdom, Sweden, Argentina, Italy, Canada, Norway
Pfizer

Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Malignant Melanoma | Carcinoma, Squamous Cell of Head and Neck

United States, Australia, Japan, France, Italy
Columbia University
National Institute of Nursing Research (NINR)

Recruiting

Effect of Hip Hop Nutrition-Math Curriculum

Health Behavior

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Unknown

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

Coronavirus

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Head and Neck Cancer | Precancerous Condition

United States, Canada
University Hospital, Rouen

Recruiting

Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid (RITUX-MMP)

Severe Forms of Mucous Membrane Pemphigoid

France
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention; Guizhou Center... and other collaborators

Recruiting

Safety Study of COVID19 Vaccine on the Market

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Zhejiang Provincial Center for Disease Control and Prevention

Recruiting

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

COVID-19

China
Beijing Sport University

Completed

Effects of COP Exercise and HIIT on Vascular Health in Young Overweight Females

Vascular Diseases

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
ImmunoFrontier, Inc.

Completed

Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer

Esophageal Cancer

Japan
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

Colo-rectal Cancer

China
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Refractory Primary Mediastinal (Thymic)... and other conditions

United States
Feng Jinzhou

Not yet recruiting

Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica Spectrum Disorders
AbbVie
Genentech, Inc.

Active, not recruiting

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Non-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid Malignancies

United States, Australia
National Cancer Institute (NCI)

Completed

Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis

Gastrointestinal Neoplasm

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

Coronavirus

China
Poitiers University Hospital

Completed

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

Metastatic Colon Cancer

France
Cliniques universitaires Saint-Luc- Université...
Merck Sharp & Dohme LLC; Merck Serono International SA

Completed

Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery (CHIRON)

Head and Neck Cancer

Belgium

Search clinical trials for: Rituximab-CHOP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations